Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL1600100	奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Import Drug Application	2016-08-31	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-01-20	view
JXHL1600101	奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Import Drug Application	2016-08-31	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-01-20	view
JTH2100638	奥希替尼薄膜衣片	osimertinib mesylate	Tablet	Chemical Drugs	Disposable Import Drug Application	2021-09-03					view
JYHB2400005	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2024-01-04		AstraZeneca AB			view
JYHZ2100526	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	License Renew	2021-04-23					view
JYHB2001171	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-07-04	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-09-04	view
JYHB1701074	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2017-08-21	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2018-02-13	view
JYHB2101572	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-12-09		AstraZeneca AB			view
JYHB2100140	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-02-20	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2021-09-23	view
JXHL1800075	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(2.4)	Import Drug Application	2018-07-09		AstraZeneca AB	Certificate Issued	2018-09-04	view
JXHL2300319	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(2.4)	Import Drug Application	2023-12-22					view
JYHZ2100525	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	License Renew	2021-04-23					view
JYHB2000291	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-04-01	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-05-25	view
JYHB2400368	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2024-07-17		AstraZeneca AB			view
JXHB2200040	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(2.4)	Supplementary Application	2022-03-24		AstraZeneca AB			view
JYHB2002228	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2020-11-05	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Filed	2020-11-24	view
JYHB1800012	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2018-01-12	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Approval Completed-Pending Certificated	2018-02-01	view
JYHB2300485	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2023-08-29		AstraZeneca AB			view
JYHB2101571	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-12-09		AstraZeneca AB			view
JXHS1800054	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Import Drug Application	2018-10-29	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2019-09-03	view